Descriptive and Functional Genomics in Acute Myeloid Leukemia (AML): Paving the Road for a Cure

SIMPLE SUMMARY: Acute myeloid leukemia (AML) accounts for 7.6% of hematopoietic malignancies with a long-term survival of less than 20%. Better understanding its physiopathology and finding new treatments remain important issues. In the current review, the authors discuss how genetic engineering tec...

Descripción completa

Detalles Bibliográficos
Autores principales: Pasquer, Hélène, Tostain, Maëlys, Kaci, Nina, Roux, Blandine, Benajiba, Lina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916915/
https://www.ncbi.nlm.nih.gov/pubmed/33670178
http://dx.doi.org/10.3390/cancers13040748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916915/
https://www.ncbi.nlm.nih.gov/pubmed/33670178
http://dx.doi.org/10.3390/cancers13040748

Ejemplares similares